Aarmed Formulations Private Limited, a active private limited company, was established on 03 January 2000 in Gorakhpur, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231UP2000PTC025014. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.72 M.
It upholds a compliant status. Employing 14 professional, Its leadership includes Jyoti Kumar Agrawal (Director), Pooja Agrawal (Director). Past directors included Sharda Devi, Atma Ram Agrawal, Ritu Devi Agrawal. It holds ₹11.49 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Sri Aatma Ram Kasia Road, Gorakhpur, Uttar Pradesh, 273001.
U24231UP2000PTC025014
025014
03 January 2000
₹1.00 Cr
₹9.72 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Aarmed Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoti Kumar Agrawal | Director | 03 Jan 2000 | Current |
| Pooja Agrawal | Director | 08 Feb 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2013 | Past |
| Pramod Abcsdd | Director | 08 Feb 2021 | Past |
| Pramod Abcsdd | Director | 01 Jun 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aarmed Formulations Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 47.78% increase. The company also saw a substantial improvement in profitability, with a 232.93% increase in profit. The company's net worth Soared by an impressive increase of 62.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Aarmed Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹114,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2025 | Others | ₹3.50 M | Open |
| 22 Nov 2019 | Others | ₹10.48 Cr | Open |
| 03 Oct 2016 | Others | ₹6.60 M | Open |
Explore comprehensive loan charge details -
Aarmed Formulations has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aarmed Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarmed Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 0.35 Cr with Charge ID 101168877 was registered on 02 Jul 2025. was documented.
Progress on Aarmed Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Aarmed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
Progress on A charge with Others of Rs. 10.48 Cr registered on 22 Nov 2019 with Charge ID 100307559 was modified on 19 Jan 2024. was documented.
The activity Pooja Agrawal was appointed as a Director was appointed as a Director on 08 Feb 2021 & has been associated with this company since 4 years 9 months . was completed.
The activity A charge with Others amounted to Rs. 10.48 Cr with Charge ID 100307559 was registered on 22 Nov 2019. was completed.
The CIN of Aarmed Formulations Private Limited is U24231UP2000PTC025014.
Aarmed Formulations Private Limited is headquartered at C/O Sri Aatma Ram Kasia Road, Gorakhpur, Uttar Pradesh, 273001.
Aarmed Formulations Private Limited was incorporated on 03 January 2000.
The current directors of Aarmed Formulations Private Limited are
The primary industry of Aarmed Formulations Private Limited is Trade.
Aarmed Formulations Private Limited is unlisted.
The authorized capital of Aarmed Formulations Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.72 M.
The compliance status of Aarmed Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX